CAI
HEALTHCARECaris Life Sciences, Inc. Common Stock
AI Insight
What's Moving CAI Today?
No stock-specific AI insight has been generated for CAI yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$14.19$42.50
$18.24
Fundamentals
Market Cap$5.0B
P/E Ratio—
EPS$-2.76
Dividend Yield—
Dividend / Share—
ROE28.3%
Profit Margin3.8%
Debt / Equity—
Trading
Volume1.8M
Avg Volume (10D)—
Shares Outstanding282.7M
CAI News
21 articles- Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood TestYahoo Finance·Jul 1, 2026
- Is Caris Life Sciences, Inc. (CAI) Stock Positioned for Growth With AI-Driven Precision Medicine Expansion?Yahoo Finance·Jun 30, 2026
- Is Caris Life Sciences, Inc. (CAI) A Good Stock To Buy Now?Yahoo Finance·Jun 19, 2026
- Caris Life Sciences (CAI) Announces $100M Share Repurchase ProgramYahoo Finance·Jun 17, 2026
- Caris Life Sciences Announces That It’s Dual Listing on NYSE TexasYahoo Finance·Jun 16, 2026
- Caris Life Sciences Announces Dual Listing on NYSE TexasYahoo Finance·Jun 16, 2026
- Caris Life Sciences Announces Share Repurchase ProgramYahoo Finance·Jun 8, 2026
- Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic TestingYahoo Finance·May 26, 2026
- You’ve Likely Never Heard of Caris Life Sciences Stock. Billionaire Stanley Druckenmiller Has – and He Likes What He Sees.Barchart·May 20, 2026
- Caris Life Sciences Advances Precision Oncology As Shares Trade Below TargetsYahoo Finance·May 19, 2026
- Another billionaire dumps mega-cap stock for AI betThe Street·May 18, 2026
- Stanley Druckenmiller Just Exited Alphabet. TCI Fund Management Is Buying.Yahoo Finance·May 15, 2026
- Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with Caris MI Cancer SeekYahoo Finance·May 15, 2026
- Caris Life Sciences Eyes Bigger Oncology Market After IPO as Revenue Jumps 79%Marketbeat·May 13, 2026
- Director buys 31K Caris Life Sciences (CAI) shares around $16.15Stock Titan·May 12, 2026
- Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene PanelsYahoo Finance·May 11, 2026
- Should Caris’s Q1 Revenue Surge and New AI Cancer Tests Require Action From Caris Life Sciences (CAI) Investors?Yahoo Finance·May 9, 2026
- Assessing Caris Life Sciences (CAI) Valuation As Shares Trade Below Narrative Fair ValueYahoo Finance·May 9, 2026
- Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing AuthorizationYahoo Finance·May 8, 2026
- Caris (CAI) Q1 2026 Earnings Call TranscriptMotley Fool·May 7, 2026
- Caris Life Sciences Q1 Earnings Call HighlightsMarketbeat·May 7, 2026
All 21 articles loaded
Price Data
Open$19.01
Previous Close$18.75
Day High$19.68
Day Low$18.14
52 Week High$42.50
52 Week Low$14.19
52-Week Range
$14.19$42.50
$18.24
Fundamentals
Market Cap$5.0B
P/E Ratio—
EPS$-2.76
Dividend Yield—
Dividend / Share—
ROE28.3%
Profit Margin3.8%
Debt / Equity—
Trading
Volume1.8M
Avg Volume (10D)—
Shares Outstanding282.7M
About Caris Life Sciences, Inc. Common Stock
CAI International, Inc. is a transportation finance company in the United States, Switzerland, France, Korea, Singapore, Rest of Asia, Rest of Europe, and internationally. The company is headquartered in San Francisco, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—